Does ATEZOLIZUMAB Cause Immune-mediated enterocolitis? 156 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Immune-mediated enterocolitis have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.5% of all adverse event reports for ATEZOLIZUMAB.
156
Reports of Immune-mediated enterocolitis with ATEZOLIZUMAB
0.5%
of all ATEZOLIZUMAB reports
23
Deaths
89
Hospitalizations
How Dangerous Is Immune-mediated enterocolitis From ATEZOLIZUMAB?
Of the 156 reports, 23 (14.7%) resulted in death, 89 (57.1%) required hospitalization, and 8 (5.1%) were considered life-threatening.
Is Immune-mediated enterocolitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 156 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Immune-mediated enterocolitis?
NIVOLUMAB (1,289)
IPILIMUMAB (988)
PEMBROLIZUMAB (858)
CARBOPLATIN (307)
PACLITAXEL (188)
DURVALUMAB (165)
LENVATINIB (143)
PEMETREXED (129)
BEVACIZUMAB (92)
TREMELIMUMAB\TREMELIMUMAB-ACTL (63)
Which ATEZOLIZUMAB Alternatives Have Lower Immune-mediated enterocolitis Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN